Decipher Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve 1. Unaudited Standalone and Consolidated Financial Results for the Quarter ended 30th September, 2026. 2. Limited Review Report for the quarter ended 30th September, 2026. 3. Any other item with the permission of Chair.

DECIPHER Regd.Off: A-2, Q2, 5th Floor, Cyber Towers, Hitech City, Madhapur, Hyderabad, Shaikpet, Telangana, India, 500081 L ABS L IMITE D Ph: (+91)-40-48536100 Url: www.decipherlabs.in Mail: decipherlabsltd@gmail.com Formerly Combat Drugs Limited D.L. No. TG/15/04/2016-14766/14767 CINNo.L24230TG1986PLC006781 GST:36AAACC8372L1ZB To Date: 10.11.2026 The Manager BSE Limited P. J. Towers, Dalal Street Mumbai-400001 Dear Sir/ Madam, Unit: Decipher Labs Limited (Scrip: 524752) Sub: Intimation of the Board Meeting to be held on Saturday, 14th November, 2026 Pursuant to Regulation 29 read with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform the Exchange that the Board Meeting of the Company will be held on Saturday, 14th November, 2026 at the registered office of the Company to consider inter alia, the following: 1. Un-audited financial results (Standalone and Consolidated) for the Quarter and Half Year ended 30th September, 2026. 2. Limited Review Report (Standalone and Consolidated) for the quarter ended 30th September, 2026. 3. Any other business with the permission of the Chair. Thanking you. Yours sincerely, For Decipher Labs Limited Dalavath Amarsingh Executive Director (DIN- 02206249)